Estrella Immunopharma, INC. (ESLAW) SEC Filings — 2024
19 SEC filings for Estrella Immunopharma, INC. (ESLAW) in 2024.
Filings
- Estrella Immunopharma Files 8-K: Other Event Reported — 8-K · Dec 16, 2024
- Estrella Immunopharma Files 8-K on Material Agreement — 8-K · Dec 6, 2024
- Estrella Immunopharma Changes Fiscal Year End — 8-K · Nov 26, 2024
- Estrella Immunopharma Faces Delisting Notice — 8-K · Nov 25, 2024
- Estrella Immunopharma Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Estrella Immunopharma Files 8-K/A for Officer Departures & Director Changes — 8-K/A · Nov 7, 2024
- Estrella Immunopharma Files 10-K/A Amendment — 10-K/A · Oct 28, 2024
- Estrella Immunopharma Files 2024 Annual Report — 10-K · Sep 27, 2024
- Estrella Immunopharma Appoints New CMO & CSO, CMO Departs — 8-K · Aug 20, 2024
- Estrella Immunopharma Files 8-K with Financials — 8-K · Aug 6, 2024
- Estrella Immunopharma Files 8-K with Financials — 8-K · Jul 2, 2024
- Estrella Immunopharma, Inc. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 15, 2024
- Estrella Immunopharma Files 8-K for Material Agreement — 8-K · May 13, 2024
- Estrella Immunopharma Files 8-K — 8-K · Apr 10, 2024
- Estrella Immunopharma Files 8-K — 8-K · Mar 11, 2024
- Estrella Immunopharma Files 8-K for Material Agreement — 8-K · Mar 7, 2024
- Estrella Immunopharma, Inc. Files 10-Q for Period Ended December 31, 2023 — 10-Q · Feb 14, 2024
- Estrella Immunopharma Changes Certifying Accountant — 8-K · Feb 2, 2024
- Estrella Immunopharma Files Routine 8-K on Jan 30 — 8-K · Jan 30, 2024